vs

Side-by-side financial comparison of Clorox (CLX) and International Flavors & Fragrances (IFF). Click either name above to swap in a different company.

Clorox is the larger business by last-quarter revenue ($4.8B vs $2.6B, roughly 1.8× International Flavors & Fragrances). On growth, International Flavors & Fragrances posted the faster year-over-year revenue change (-6.6% vs -6.7%). Clorox produced more free cash flow last quarter ($637.0M vs $130.0M). Over the past eight quarters, Clorox's revenue compounded faster (62.2% CAGR vs -5.5%).

The Clorox Company is an American multinational manufacturer and marketer of consumer and professional products. Clorox ranked annually on the Fortune 500 list from 2000 to 2024, where it last held the #485 spot.

International Flavors & Fragrances Inc. (IFF) is an American corporation that creates products across taste, texture, scent, nutrition, enzymes, cultures, soy proteins, and probiotics categories, which it markets globally. It is headquartered in New York City and has creative, sales, and manufacturing facilities in 44 countries. The company is a member of the S&P 500 index.

CLX vs IFF — Head-to-Head

Bigger by revenue
CLX
CLX
1.8× larger
CLX
$4.8B
$2.6B
IFF
Growing faster (revenue YoY)
IFF
IFF
+0.2% gap
IFF
-6.6%
-6.7%
CLX
More free cash flow
CLX
CLX
$507.0M more FCF
CLX
$637.0M
$130.0M
IFF
Faster 2-yr revenue CAGR
CLX
CLX
Annualised
CLX
62.2%
-5.5%
IFF

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
CLX
CLX
IFF
IFF
Revenue
$4.8B
$2.6B
Net Profit
$5.0M
Gross Margin
34.4%
Operating Margin
3.7%
Net Margin
0.2%
Revenue YoY
-6.7%
-6.6%
Net Profit YoY
110.9%
EPS (diluted)
$0.03

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLX
CLX
IFF
IFF
Q1 26
$4.8B
Q4 25
$1.7B
$2.6B
Q3 25
$2.7B
Q2 25
$2.0B
$2.8B
Q1 25
$1.7B
$2.8B
Q4 24
$1.7B
$2.8B
Q3 24
$1.8B
$2.9B
Q2 24
$1.9B
$2.9B
Net Profit
CLX
CLX
IFF
IFF
Q1 26
Q4 25
$157.0M
$5.0M
Q3 25
$40.0M
Q2 25
$332.0M
$612.0M
Q1 25
$186.0M
$-1.0B
Q4 24
$193.0M
$-46.0M
Q3 24
$99.0M
$59.0M
Q2 24
$216.0M
$170.0M
Gross Margin
CLX
CLX
IFF
IFF
Q1 26
Q4 25
43.2%
34.4%
Q3 25
36.5%
Q2 25
46.5%
37.3%
Q1 25
44.6%
36.4%
Q4 24
43.8%
35.4%
Q3 24
45.8%
36.0%
Q2 24
46.5%
37.0%
Operating Margin
CLX
CLX
IFF
IFF
Q1 26
Q4 25
3.7%
Q3 25
8.4%
Q2 25
20.6%
7.2%
Q1 25
15.2%
-31.8%
Q4 24
14.1%
4.6%
Q3 24
10.0%
8.5%
Q2 24
14.5%
6.6%
Net Margin
CLX
CLX
IFF
IFF
Q1 26
Q4 25
9.4%
0.2%
Q3 25
1.5%
Q2 25
16.7%
22.1%
Q1 25
11.2%
-35.8%
Q4 24
11.4%
-1.7%
Q3 24
5.6%
2.0%
Q2 24
11.4%
5.9%
EPS (diluted)
CLX
CLX
IFF
IFF
Q1 26
Q4 25
$1.29
$0.03
Q3 25
$0.16
Q2 25
$2.68
$2.38
Q1 25
$1.50
$-3.98
Q4 24
$1.54
$-0.17
Q3 24
$0.80
$0.23
Q2 24
$1.74
$0.66

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLX
CLX
IFF
IFF
Cash + ST InvestmentsLiquidity on hand
$590.0M
Total DebtLower is stronger
$5.6B
Stockholders' EquityBook value
$14.2B
Total Assets
$25.5B
Debt / EquityLower = less leverage
0.40×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLX
CLX
IFF
IFF
Q1 26
Q4 25
$227.0M
$590.0M
Q3 25
$621.0M
Q2 25
$167.0M
$816.0M
Q1 25
$226.0M
$613.0M
Q4 24
$290.0M
$469.0M
Q3 24
$278.0M
$567.0M
Q2 24
$202.0M
$671.0M
Total Debt
CLX
CLX
IFF
IFF
Q1 26
Q4 25
$5.6B
Q3 25
Q2 25
$2.5B
Q1 25
Q4 24
$8.9B
Q3 24
Q2 24
$2.5B
Stockholders' Equity
CLX
CLX
IFF
IFF
Q1 26
Q4 25
$-125.0M
$14.2B
Q3 25
$14.2B
Q2 25
$321.0M
$14.4B
Q1 25
$27.0M
$13.2B
Q4 24
$-41.0M
$13.9B
Q3 24
$60.0M
$14.8B
Q2 24
$328.0M
$14.3B
Total Assets
CLX
CLX
IFF
IFF
Q1 26
Q4 25
$5.6B
$25.5B
Q3 25
$25.8B
Q2 25
$5.6B
$26.1B
Q1 25
$5.5B
$28.3B
Q4 24
$5.6B
$28.7B
Q3 24
$5.5B
$29.9B
Q2 24
$5.8B
$29.5B
Debt / Equity
CLX
CLX
IFF
IFF
Q1 26
Q4 25
0.40×
Q3 25
Q2 25
7.74×
Q1 25
Q4 24
0.64×
Q3 24
Q2 24
7.56×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLX
CLX
IFF
IFF
Operating Cash FlowLast quarter
$318.0M
Free Cash FlowOCF − Capex
$637.0M
$130.0M
FCF MarginFCF / Revenue
13.3%
5.0%
Capex IntensityCapex / Revenue
2.5%
7.3%
Cash ConversionOCF / Net Profit
63.60×
TTM Free Cash FlowTrailing 4 quarters
$256.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLX
CLX
IFF
IFF
Q1 26
Q4 25
$318.0M
Q3 25
$164.0M
Q2 25
$294.0M
$241.0M
Q1 25
$286.0M
$127.0M
Q4 24
$180.0M
$368.0M
Q3 24
$221.0M
$366.0M
Q2 24
$340.0M
$237.0M
Free Cash Flow
CLX
CLX
IFF
IFF
Q1 26
$637.0M
Q4 25
$130.0M
Q3 25
$32.0M
Q2 25
$219.0M
$146.0M
Q1 25
$233.0M
$-52.0M
Q4 24
$127.0M
$208.0M
Q3 24
$182.0M
$263.0M
Q2 24
$259.0M
$155.0M
FCF Margin
CLX
CLX
IFF
IFF
Q1 26
13.3%
Q4 25
5.0%
Q3 25
1.2%
Q2 25
11.0%
5.3%
Q1 25
14.0%
-1.8%
Q4 24
7.5%
7.5%
Q3 24
10.3%
9.0%
Q2 24
13.6%
5.4%
Capex Intensity
CLX
CLX
IFF
IFF
Q1 26
2.5%
Q4 25
7.3%
Q3 25
4.9%
Q2 25
3.8%
3.4%
Q1 25
3.2%
6.3%
Q4 24
3.1%
5.8%
Q3 24
2.2%
3.5%
Q2 24
4.3%
2.8%
Cash Conversion
CLX
CLX
IFF
IFF
Q1 26
Q4 25
63.60×
Q3 25
4.10×
Q2 25
0.89×
0.39×
Q1 25
1.54×
Q4 24
0.93×
Q3 24
2.23×
6.20×
Q2 24
1.57×
1.39×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLX
CLX

Segment breakdown not available.

IFF
IFF

Food Ingredients$802.0M31%
Scent$610.0M24%
Other$589.0M23%
Taste$588.0M23%

Related Comparisons